Tegaserod Maleate (Zelnorm) for IBS with Constipation
Tegaserod maleate (teg a ser' od; Zelnorm - Novartis), a serotonin derivative, has received FDA approval for short-term treatment of women with irritable bowel syndrome (IBS) whose primary symptom is constipation. Alosetron (Lotronex), which was withdrawn previously because of toxicity, will soon be available again for women with severe diarrhea-predominant IBS (Medical Letter 2002; 44:67)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Tegaserod Maleate (Zelnorm) for IBS with Constipation
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1139
Article Code: 1139a
Date: September 16, 2002
Volume: 44
Pages: 79-80
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1139
Article Code: 1139a
Date: September 16, 2002
Volume: 44
Pages: 79-80
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)